Dr Reddys Laboratories (RDY) Intangibles (2009 - 2026)
Dr Reddys Laboratories (RDY) reported Intangibles of $1.09 billion for the quarter ended Jun 30, 2026, down 2.0% from $1.12 billion a year earlier and down 4.8% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Intangibles (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Dr Reddys Laboratories posted Intangibles of $1.12 billion, down 1.2% from the prior year.
- Intangibles has a five-year compound annual growth rate of 18.1% (years ended Mar 2021 to Mar 2026).
- By year, Intangibles came in at $1.13 billion in the year ended Mar 31, 2025 (+156.0%), $443 million in the year ended Mar 31, 2024 (+18.1%), $375 million in the year ended Mar 31, 2023 (+4.5%) and $359 million in the year ended Mar 31, 2022 (-26.3%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Intangibles since the quarter ended Jun 30, 2024.
- Year over year, Intangibles gained in seven of the last eight quarters, with growth averaging 75.8%.
- The high point for year-over-year Intangibles in five years was the quarter ended Mar 31, 2025 (growth of 151.2%); the low point was the quarter ended Mar 31, 2022 (a decline of 25.9%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $1.15 billion (quarter ended Mar 31, 2026), $1.15 billion (quarter ended Dec 31, 2025) and $1.16 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Dr Reddys Laboratories | 10.53 Bn | 9.72 Bn | 396.53 Mn | 1.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Bn |
| Mar 31, 2026 | 1.15 Bn |
| Dec 31, 2025 | 1.15 Bn |
| Sep 30, 2025 | 1.16 Bn |
| Jun 30, 2025 | 1.12 Bn |
| Mar 31, 2025 | 1.12 Bn |
| Dec 31, 2024 | 1.10 Bn |
| Sep 30, 2024 | 1.10 Bn |
| Jun 30, 2024 | 445.12 Mn |
| Mar 31, 2024 | 444.95 Mn |
| Dec 31, 2023 | 443.23 Mn |
| Sep 30, 2023 | 448.25 Mn |
| Jun 30, 2023 | 463.35 Mn |
| Mar 31, 2023 | 375.27 Mn |
| Dec 31, 2022 | 376.43 Mn |
| Sep 30, 2022 | 398.31 Mn |
| Jun 30, 2022 | 412.81 Mn |
| Mar 31, 2022 | 362.35 Mn |
| Dec 31, 2021 | 427.56 Mn |
| Sep 30, 2021 | 440.38 Mn |
API Access
Dr Reddys Laboratories Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();